ResMed Inc. (ASX:RMD)
Australia · Delayed Price · Currency is AUD 37.30
+0.20 (0.54%)
At close: Jan 9, 2026
ResMed Market Cap
ResMed has a market cap or net worth of 54.64 billion as of January 9, 2026. Its market cap has decreased by -1.93% in one year.
Market Cap
54.64B
Enterprise Value
53.83B
Revenue
7.95B
Ranking
n/a
PE Ratio
25.13
Stock Price
37.30
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 53.86M to 54.64B, an increase of 101,339.34%. That is a compound annual growth rate of 25.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 54.64B | 3.81% |
| Dec 31, 2025 | 52.63B | -3.01% |
| Dec 31, 2024 | 54.27B | 46.20% |
| Dec 29, 2023 | 37.12B | -17.49% |
| Dec 30, 2022 | 44.98B | -14.11% |
| Dec 31, 2021 | 52.37B | 31.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 81.96B |
| Pro Medicus | 22.46B |
| Cochlear | 17.17B |
| Sonic Healthcare | 10.94B |
| Ramsay Health Care | 8.20B |
| Ansell | 5.07B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |